(Q34496962)

2 August 2017

title

Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis (English)

1 reference

2 August 2017

A. K. Azad Khan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6105118

6 August 2023

D. T. Howes

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6105118

6 August 2023

J. Piris

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6105118

6 August 2023

S. C. Truelove

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6105118

6 August 2023

language of work or name

English

0 references

publication date

1 March 1980

1 reference

full work available at URL

2 August 2017

https://europepmc.org/articles/PMC1420362

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6105118

https://europepmc.org/articles/PMC1420362?pdf=render

6 August 2023

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6105118

https://syndication.highwire.org/content/doi/10.1136/gut.21.3.232

6 August 2023

1 reference

https://api.crossref.org/works/10.1136/GUT.21.3.232

6 August 2023

1 reference

2 August 2017

volume

21

1 reference

2 August 2017

issue

3

1 reference

2 August 2017

page(s)

232-240

1 reference

CONTROLLED TRIAL OF SULPHASALAZINE IN THE TREATMENT OF ULCERATIVE COLITIS.

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420362

Peripheral neuritis due to isoniazid.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420362

Further studies on the properties and assay of glucose 6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase of rat liver

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420362

An improved and simplified method of detecting the acetylator phenotype

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420362

Acetylator phenotype and adverse effects of sulphasalazine in healthy subjects

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420362

Azulfidine agranulocytosis with bone marrow, megakaryocytosis, histiocytosis and plasmacytosis.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420362

Adverse reactions to salicylazosulfapyridine (azulfidine) in the treatment of ulcerative colitis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420362

A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin).

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420362

Letter: Hemolytic anemia as adverse reaction to salicylazosulfapyridine

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420362

The metabolism of salicylazosulphapyridine in ulcerative colitis. I. The relationship between metabolites and the response to treatment in inpatients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420362

[Mechanism of hemiglobin formation by salicylazosulfapyridine (azulfidine)]

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420362

Determination of sulphapyridine and its metabolites in biological materials after administration of salicylazosulphapyridine.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420362

Red cell abnormalities associated with sulphasalazine maintenance therapy for ulcerative colitis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420362

THE OCCURRENCE OF HEINZ BODIES DURING AZULFIDINE TREATMENT OF ULCERATIVE COLITIS.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420362

An assessment of prednisone, salazopyrin, and topical hydrocortisone hemisuccinate used as out-patient treatment for ulcerative colitis

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420362

Biopsy studies in ulcerative colitis.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1420362

Heinz-body anaemia due to salicylazosulphapyridine

27 October 2018

1 reference

12 December 2020

Sulphasalazine and salicylazosulphadimidine in ulcerative colitis

1 reference

12 December 2020

Metabolism of isoniazid in man as related to the occurrence of peripheral neuritis

1 reference

12 December 2020

A critical analysis of the use of salicylazosulfapyridine in chronic ulcerative colitis

1 reference

12 December 2020

Determination of salicylazosulphapyridine in biological materials

1 reference

12 December 2020

Comparison of corticosteroid and sulphasalazine therapy in ulcerative colitis

1 reference

12 December 2020

THE INFLUENCE OF ACETYLATOR PHENOTYPE ON THE EFFECTS OF TREATING DEPRESSION WITH PHENELZINE.

1 reference

12 December 2020

Determination of free and acetylated 5-aminosalicylic acid in serum and urine after administration of salicylazosulphapyridine

1 reference

12 December 2020

Impaired folic acid absorption in inflammatory bowel disease: effects of salicylazosulfapyridine (Azulfidine)

1 reference

12 December 2020

Results of treatment of ulcerative colitis with salicylazosulfapyridine

1 reference

12 December 2020

The sulphonamides

https://api.crossref.org/works/10.1136/GUT.21.3.232

22

1 reference

6 August 2023

Identifiers

DOI

10.1136/GUT.21.3.232

1 reference

2 August 2017

1 reference

2 August 2017

1 reference